Charles Schwab Investment Management Inc Procept Bio Robotics Corp Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 341,291 shares of PRCT stock, worth $23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
341,291
Previous 335,117
1.84%
Holding current value
$23 Million
Previous $14 Million
20.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PRCT
# of Institutions
179Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$359 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$286 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$222 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$198 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$134 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.01B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...